Author: Alan Condon

The American Orthopaedic Society for Sports Medicine on April 30 canceled its 2020 Annual Meeting.

Florida hospitals are preparing to resume elective surgeries May 4 in accordance with Gov. Ron DeSantis' recent guidance.

The FDA on April 30 provided 510(k) clearance for Astura Medical's El Capitan anterior lumbar interbody fusion system.

Philadelphia-based Rothman Orthopaedic Institute may lose $120 million in revenue this year due to the cessation of elective surgeries caused by the COVID-19 pandemic, the Philadelphia Business Journal reports.

An angel investor on April 30 proposed a $30 million loan to help restructure private medical cannabis company Green Relief.

Neurosurgeon Michael McDermott, MD, on April 30 was appointed chief medical executive of Miami Neuroscience Institute, formerly Baptist Health Neuroscience Center, P&T Community reports.

3D-imaging startup nView Medical partnered with OrthoGrid on April 30 to combine their imaging and alignment technologies for orthopedic surgeries, The Herald Journal reports.

Baltimore-based Johns Hopkins University on April 29 launched the COVID-19 Testing Insights Initiative to track testing in the U.S. and provide guidance for the public.

Richard Chua, MD, a neurosurgeon with Northwest NeuroSpecialists in Tucson, Ariz., spoke to Becker's Spine Review about how his practice has been affected by the COVID-19 pandemic and steps he is taking to return to elective surgeries on May 1.

Here are five orthopedic surgeons making the news this week: